Trihal Pharma Private Limited

Trihal Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24290MH2021PTC359068 Incorporated 16 April 2021 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Revenue · FY 2025
₹4.36 Cr
▲ 828% YoY
Net loss · FY 2025
₹9.14 Cr
Net margin -209.8%
EBITDA · FY 2025
-₹3.83 Cr
EBITDA margin -87.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Trihal Pharma Private Limited

Data last updated:

Trihal Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 April 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2021PTC359068. Its GSTIN is 27AAICT5691H1ZU (Maharashtra).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Trihale Pharma Private Limited. It is led by directors including Manish Mangilal Shah and Amit Bansal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 21 A 2nd Flr Vasudev Chamber Nr. Andheri Subway Old Nagardas X Road Andheri East, Mumbai, Maharashtra, India – 400069.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.36 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹9.14 Cr (net margin -209.8%) and EBITDA of -₹3.83 Cr (EBITDA margin -87.8%).

Its group structure includes 1 subsidiary.

Company details

CIN U24290MH2021PTC359068
Registration Number 359068
Incorporation Date 16 April 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active

Contact details

Trihal Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    21 A 2nd Flr Vasudev Chamber Nr. Andheri Subway Old Nagardas X Road Andheri East, Mumbai, Maharashtra, India – 400069
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Trihal Pharma Private Limited, buy the company report.

Comprehensive company report
Trihal Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Trihal Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing20Manufacture of chemicals and chemical products

To see the full business activity and turnover split of Trihal Pharma Private Limited, buy the company report.

Financials of Trihal Pharma Private Limited

FY 2025 filings available

Trihal Pharma Private Limited reported revenue of ₹4.36 Cr (up 828% YoY) for FY 2025.

Revenue · FY 2025
₹4.36 Cr ▲ 828%
Net loss · FY 2025
₹9.14 Cr margin -209.8%
EBITDA · FY 2025
-₹3.83 Cr margin -87.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 828%
EBITDA CAGR growth
3 years · compounded
▼ 175%

Revenue rose 828% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹3.83 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹9.14 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin-87.8%
Net Profit Margin-209.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Trihal Pharma Private Limited, buy the company report.

Board of directors of Trihal Pharma Private Limited

Trihal Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Manish Mangilal ShahDirector01 Feb 20224 Years 9 MonthsCurrent
Amit BansalDirector01 Feb 20224 Years 9 MonthsCurrent
Shekhar Shrawankumar BhuwaniaDirector16 Apr 20215 Years 7 MonthsCurrent

Auditor

Trihal Pharma Private Limited is audited by Vanita Bhuva & Co for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Vanita Bhuva & CoFY 2023145476W

Shareholding

The shareholding of Trihal Pharma Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Trihal Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Trihal Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Trihal Pharma has 1 subsidiary company. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Respipure Pharma Private LimitedU24290MH2022PTC375528

To see the full group structure of Trihal Pharma Private Limited, buy the company report.

GST

Trihal Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAICT5691H1ZUMaharashtraActive04 Nov 2021

To see the full GST registrations and return filing status of Trihal Pharma Private Limited, buy the company report.

Recent activity

Trihal Pharma Private Limited has 11 board changes on record since 2021: 7 appointments and 4 cessations. The latest: Madhur Vinodkumar Gupta ceased to be Director on 16 Dec 2024.

AGM
Trihal Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Trihal Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Madhur Vinodkumar Gupta ceased to be Director.
Ceased
Nitin Ganpati Kulkarni ceased to be Additional Director.
Ceased
Nishant Vaish ceased to be Additional Director.
Appointed
Madhur Vinodkumar Gupta was appointed as Director.
Ceased
Ravi Jaisalmeria ceased to be Director.
Appointed
Amit Bansal was appointed as Director.
Appointed
Manish Mangilal Shah was appointed as Director.
Appointed
Nishant Vaish was appointed as Additional Director.
Appointed
Nitin Ganpati Kulkarni was appointed as Additional Director.
Appointed
Ravi Jaisalmeria was appointed as Director.

2 earlier events are in the company report.

Frequently asked questions

Trihal Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 April 2021 (5+ years old) and is registered under CIN U24290MH2021PTC359068.

Trihal Pharma has 3 current directors:

The latest financial statements of Trihal Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Trihal Pharma is 27AAICT5691H1ZU, registered in Maharashtra.

The CIN (Corporate Identification Number) of Trihal Pharma is U24290MH2021PTC359068. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Trihal Pharma was incorporated on 16 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.

Madhur Vinodkumar Gupta ceased to be Director on 16 Dec 2024. Nitin Ganpati Kulkarni ceased to be Additional Director on 31 May 2024. Nishant Vaish ceased to be Additional Director on 24 Jun 2022. Trihal Pharma has 11 board changes on record in total.

The registered office of Trihal Pharma is at 21 A 2nd Flr Vasudev Chamber Nr. Andheri Subway Old Nagardas X Road Andheri East, Mumbai, Maharashtra, India – 400069.

Trihal Pharma operates in the pharma industry, in the drug formulation and development segment.

Trihal Pharma has 1 subsidiary company including Respipure Pharma Private Limited.